This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Book Now
Menu
Book Now

Dr. Tsubasa Aoki, PhD
Researcher at Ajinomoto Co.
Speaker

Agenda Sessions

  • Pioneering the Development of Highly Stable Site-Specific Antibody-Oligonucleotide Conjugates (AOC) Using Fc-Targeting Reagents

    , 8:45am
    View Session

At this event

Prev
Next
Dr. Kerry Blanchard, MD, PhD
CEO, Chairman and Founder
Perpetual Medicines

See Tsubasa at TIDES Asia: Oligonucleotide & Peptide Therapeutics

Book Now